Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Propranolol × Clear all

NCT05451043 2025-06-26

Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Liver Neoplasms, Pancreatic Neoplasms, Cholangiocarcinoma

NCT06145074 2024-03-28

IMPULS

Phase 2 Recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT03838029 2019-11-20

BC-PC

Phase 2 Unknown

Gastrointestinal

Pancreatic Neoplasms